Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine: Its Effects on Suicidal Ideations and Inpatient Hospital Length of Stay

NCT02997722 is registered in ClinicalTrials.gov with Allen Richert as lead sponsor.

NCT NCT02997722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02997722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine: Its Effects on Suicidal Ideations and Inpatient Hospital Length of Stay
Lead sponsor
Allen Richert
Phase
Phase 4
Overall status
Terminated
Start date
March 2, 2017
Completion date
May 19, 2017
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

suicidal ideation